Aliases & Classifications for Fibroma

MalaCards integrated aliases for Fibroma:

Name: Fibroma 12 77 30 56 45 15 17

Classifications:



External Ids:

Disease Ontology 12 DOID:0050871
MeSH 45 D005350

Summaries for Fibroma

Disease Ontology : 12 A connective tissue benign neoplasm composed of fibrous or connective tissues that derives from mesenchymal tissue.

MalaCards based summary : Fibroma is related to chondromyxoid fibroma and fibromatosis. An important gene associated with Fibroma is MALAT1 (Metastasis Associated Lung Adenocarcinoma Transcript 1), and among its related pathways/superpathways are Cytoskeleton remodeling Neurofilaments and Striated Muscle Contraction. The drugs Anesthetics and Anesthetics, Local have been mentioned in the context of this disorder. Affiliated tissues include bone, heart and ovary, and related phenotypes are cellular and cardiovascular system

Wikipedia : 77 Fibromas are benign tumors that are composed of fibrous or connective tissue. They can grow in all... more...

Related Diseases for Fibroma

Diseases related to Fibroma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 354)
# Related Disease Score Top Affiliating Genes
1 chondromyxoid fibroma 33.4 ACTC1 COL12A1 DES S100A1 VIM
2 fibromatosis 32.5 ACTC1 CTNNB1 DES VIM
3 birt-hogg-dube syndrome 32.5 CTNNB1 PTCH1
4 cutaneous fibrous histiocytoma 31.9 ACTC1 DES F13A1 SERPINA3 VIM
5 fibrosarcoma 30.8 DES MALAT1 VIM
6 epulis 30.7 DES VIM
7 chondroma 30.3 ACTC1 CTNNB1
8 giant cell tumor 30.2 ACTC1 DES SERPINA3 VIM
9 granular cell tumor 30.2 DES SERPINA3 VIM
10 infantile digital fibromatosis 30.1 DES VIM
11 odontoma 30.1 KRT14 VIM
12 spindle cell sarcoma 30.1 ACTC1 DES VIM
13 inflammatory myofibroblastic tumor 30.1 ACTC1 DES VIM
14 ovarian fibrothecoma 30.1 ACTC1 DES
15 cutaneous leiomyosarcoma 30.1 ACTC1 DES
16 congenital epulis 30.0 CD34 DES VIM
17 pleomorphic liposarcoma 30.0 DES VIM
18 osteoblastoma 30.0 CTNNB1 USP6
19 ameloblastoma 30.0 KRT14 PTCH1 SERPINA3
20 odontogenic myxoma 30.0 SERPINA3 VIM
21 mesenchymal chondrosarcoma 30.0 DES VIM
22 erythema elevatum diutinum 29.9 CD34 F13A1
23 chordoma 29.9 DES S100A1 VIM
24 congenital fibrosarcoma 29.9 ACTC1 DES VIM
25 leiomyosarcoma 29.9 ACTC1 DES S100A1 VIM
26 leiomyoma 29.8 ACTC1 CD34 DES S100A1 VIM
27 liposarcoma 29.8 CD34 DES VIM
28 hemangiopericytoma, malignant 29.7 ACTC1 DES F13A1 VIM
29 carcinosarcoma 29.6 ACTC1 CTNNB1 DES VIM
30 dermatofibrosarcoma protuberans 29.5 ACTC1 CD34 DES F13A1 SERPINA3 VIM
31 fibrous histiocytoma 29.3 ACTC1 DES F13A1 SERPINA3 VIM
32 juvenile ossifying fibroma 12.4
33 ovarian fibroma 12.4
34 ossifying fibroma 12.4
35 discoid fibromas, familial multiple 12.3
36 testicular fibroma 12.2
37 calcifying aponeurotic fibroma 12.2
38 liver fibroma 12.1
39 osteofibrous dysplasia 12.0
40 hyperparathyroidism 2 with jaw tumors 11.9
41 basal cell nevus syndrome 11.5
42 familial adenomatous polyposis 1 11.5
43 terminal osseous dysplasia 11.5
44 leiomyoma, uterine 11.4
45 fibromatosis multiple non ossifying 11.3
46 gigantiform cementoma, familial 11.2
47 skin tag 11.2
48 encephalocraniocutaneous lipomatosis 11.0
49 bladder benign neoplasm 11.0
50 pleural disease 11.0

Graphical network of the top 20 diseases related to Fibroma:



Diseases related to Fibroma

Symptoms & Phenotypes for Fibroma

MGI Mouse Phenotypes related to Fibroma:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 9.96 ACTC1 CD34 CDC73 COL12A1 CTNNB1 DES
2 cardiovascular system MP:0005385 9.92 ACTC1 CDC73 CTNNB1 DES F13A1 PTCH1
3 homeostasis/metabolism MP:0005376 9.85 ACTC1 CD34 CDC73 CTNNB1 DES F13A1
4 muscle MP:0005369 9.56 ACTC1 CDC73 COL12A1 CTNNB1 DES PTCH1
5 respiratory system MP:0005388 9.17 CDC73 CTNNB1 F13A1 KRT14 PTCH1 S100A1

Drugs & Therapeutics for Fibroma

Drugs for Fibroma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 104)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Anesthetics Phase 4,Phase 3,Phase 2,Not Applicable
2 Anesthetics, Local Phase 4,Phase 3,Phase 2
3
Everolimus Approved Phase 3,Phase 1,Phase 2 159351-69-6 70789204 6442177
4
Sirolimus Approved, Investigational Phase 3,Phase 1,Phase 2 53123-88-9 46835353 5284616 6436030
5
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 1,Phase 2 22916-47-8 4189
6
Petrolatum Approved, Investigational Phase 2, Phase 3 8009-03-8
7
Triamcinolone Approved, Vet_approved Phase 3,Phase 1 124-94-7 31307
8
Sorafenib Approved, Investigational Phase 3 284461-73-0 216239 406563
9
Mifepristone Approved, Investigational Phase 2, Phase 3 84371-65-3 55245
10
Calcium Approved, Nutraceutical Phase 3,Phase 2 7440-70-2 271
11
Vitamin A Approved, Nutraceutical, Vet_approved Phase 3 68-26-8, 22737-96-8, 11103-57-4 9904001 445354
12 Anti-Inflammatory Agents Phase 3,Phase 2,Phase 1
13 Hormones Phase 3,Phase 2,Phase 1,Early Phase 1
14 Hormone Antagonists Phase 3,Phase 2,Phase 1,Early Phase 1
15 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2,Phase 1,Early Phase 1
16 Immunologic Factors Phase 3,Phase 2,Phase 1
17 Antifungal Agents Phase 3,Phase 1,Phase 2
18 Anti-Bacterial Agents Phase 3,Phase 1,Phase 2
19 Anti-Infective Agents Phase 3,Phase 1,Phase 2
20 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
21 Antibiotics, Antitubercular Phase 3,Phase 1,Phase 2
22 Calcium, Dietary Phase 3,Phase 2
23 glucocorticoids Phase 3,Phase 1
24 Triamcinolone hexacetonide Phase 3,Phase 1
25 triamcinolone acetonide Phase 3,Phase 1
26 retinol Phase 3
27 Retinol palmitate Phase 3
28 Triamcinolone diacetate Phase 3,Phase 1
29 Protein Kinase Inhibitors Phase 3,Phase 1,Phase 2
30 Anesthetics, General Phase 3
31 Luteolytic Agents Phase 2, Phase 3
32 Contraceptives, Oral Phase 2, Phase 3
33 Contraceptive Agents Phase 2, Phase 3
34 Contraceptives, Postcoital Phase 2, Phase 3
35
Toremifene Approved, Investigational Phase 2 89778-26-7 3005573
36
Ibuprofen Approved Phase 2 15687-27-1 3672
37
Oxycodone Approved, Illicit, Investigational Phase 2 76-42-6 5284603
38
Acetaminophen Approved Phase 2 103-90-2 1983
39
leucovorin Approved Phase 2 58-05-9 143 6006
40
Methotrexate Approved Phase 2 1959-05-2, 59-05-2 126941
41
Vinblastine Approved Phase 2 865-21-4 241903 13342
42
Tamoxifen Approved Phase 2,Phase 1 10540-29-1 2733526
43
Sulindac Approved, Investigational Phase 2 38194-50-2 1548887 5352
44
Sodium Citrate Approved, Investigational Phase 2 68-04-2
45
Sunitinib Approved, Investigational Phase 2 557795-19-4, 341031-54-7 5329102
46
Denosumab Approved Phase 2 615258-40-7
47
Aminolevulinic acid Approved Phase 2 106-60-5 137
48
Ipilimumab Approved Phase 2 477202-00-9
49
nivolumab Approved Phase 2 946414-94-4
50
Adalimumab Approved Phase 2 331731-18-1 16219006

Interventional clinical trials:

(show top 50) (show all 109)
# Name Status NCT ID Phase Drugs
1 Retreatment of Recurrent Dupuytren's Contractures Completed NCT01498640 Phase 4
2 MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex Completed NCT01450397 Phase 4
3 Efficacy and Safety of Xiaflex Injection for Treatment of Dupuytren's Contracture of the Thumb Completed NCT01265420 Phase 4
4 Prospective Trial Comparing the Performance Profiles of Two Non-Cross-Linked Porcine Dermal Matrices in Abdominal Wall Reconstruction Recruiting NCT02228889 Phase 4
5 Trial Comparing Treatment Strategies in Dupuytren's Contracture Recruiting NCT03192020 Phase 4 Collagenase Clostridium Histolyticum 2.9 MG/ML [Xiaflex]
6 Collagenase Injection vs Percutaneous Needle Aponeurotomy for Dupuytren's Disease Recruiting NCT03000114 Phase 4 XIAFLEX
7 Prospective Randomized Trial Between Needle Fasciotomy and Xiapex for Dupuytrens Contracture Recruiting NCT02476461 Phase 4 xiapex
8 Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF Active, not recruiting NCT02647619 Phase 4 Xiapex
9 Fasciectomy vs Collagenase Injection in Recurrent Dupuytren Disease Enrolling by invitation NCT03406338 Phase 4 Collagenase Clostridium Histolyticum
10 Safety and Efficacy of Delayed Manipulation After Xiaflex Treatment in Subjects With Dupuytren's Contracture Terminated NCT01226121 Phase 4
11 Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1) Completed NCT00789828 Phase 3 Everolimus;Placebo
12 Non-US Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease Completed NCT00533273 Phase 3
13 Safety and Efficacy Study of AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease Completed NCT00528840 Phase 3
14 AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease Completed NCT00528424 Phase 3
15 Collagenase in the Treatment of Dupuytrens Disease Completed NCT00260429 Phase 3
16 Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures Completed NCT01674634 Phase 3
17 Collagenase Option for Reduction of Dupuytren's Contracture in Japan Completed NCT01588353 Phase 3 Collagenase Clostridium Histolyticum
18 Administration of Two Injections for Multiple Dupuytren's Contractures Completed NCT01407068 Phase 3
19 Treatment Of Dupuytren's Contracture With Collagenase Clostridium Histolyticum Injection (Xiapex) Completed NCT01229436 Phase 3 Xiapex
20 Evaluation of the Efficiency of Autologous Platelet Gel (Platelet Rich Fibrin) Obtained From Own Patients' Blood Versus Vaselitulle in Dupuytren's Disease Postoperative Wound Healing Completed NCT00931567 Phase 2, Phase 3
21 Effects of Steroid Injection With Percutaneous Needle Aponeurotomy in Dupuytren's Contracture Completed NCT00565019 Phase 3 Triamcinolone Acetonide
22 AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Dupuytren's Contracture Completed NCT00528606 Phase 3
23 Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease Completed NCT00014742 Phase 3 collagenase
24 Study of Volume Reduction of Uterine Fibroids After Embolization or Microwave Treatment Recruiting NCT02942537 Phase 2, Phase 3
25 Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) Recruiting NCT03785964 Phase 3 Nirogacestat oral tablet;Placebo Oral Tablet
26 Ledderhose Disease: Radiotherapy or Not? Recruiting NCT03507010 Phase 3
27 Evaluation of Xiaflex: Trial of Effectivenss iN Dupuytren's Recruiting NCT02725528 Phase 3 collagenase injection
28 Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis Active, not recruiting NCT02066181 Phase 3 Sorafenib Tosylate
29 Mifepristone to Treat Uterine Fibroids Terminated NCT01786226 Phase 2, Phase 3 Oral administration of mifepristone 2.5 mg daily for three months;Oral administration of mifepristone 5 mg daily for three months
30 Collagenase and Needle Aponeurotomy: Single Modality Versus Combination Treatment for Dupuytren's Disease Withdrawn NCT01776892 Phase 3 Collegenase injection
31 Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets Unknown status NCT02353429 Phase 2 Toremifene
32 Ibuprofen Plus Acetaminophen Versus Oxycodone Alone After Hand Surgery Unknown status NCT03111186 Phase 2 Oxycodone Hcl 5Mg;Ibuprofen 400 mg;Acetaminophen 650 mg
33 Dupuytren's Disease and Extracorporeal Shockwave Therapy (DupuyShock-2010) Unknown status NCT01184586 Phase 2
34 A Phase 2, Study to Evaluate the Safety and Efficacy Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Uterine Fibroids Completed NCT02323646 Phase 2 Placebo Comparator;Proellex 6 mg;Proellex 12 mg
35 Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis Completed NCT00287846 Phase 1, Phase 2 imatinib mesylate
36 Radiation Therapy in Treating Patients With Aggressive Fibromatoses Completed NCT00030680 Phase 2
37 A Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis) Completed NCT02495519 Phase 2 Imatinib
38 Study to Evaluate Imatinib in Desmoid Tumors Completed NCT01137916 Phase 2 Imatinib
39 Vinblastine and Methotrexate in Treating Children With Desmoid Tumors Completed NCT00003019 Phase 2 methotrexate;vinblastine sulfate
40 Toremifene in Treating Patients With Desmoid Tumors Completed NCT00002595 Phase 2 toremifene
41 Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor Completed NCT00068419 Phase 2 tamoxifen citrate;sulindac
42 Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules Completed NCT02193828 Phase 2
43 Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas Completed NCT00474994 Phase 2 sunitinib malate
44 Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease Completed NCT00004409 Phase 2 collagenase
45 Open Label Immunotherapy of Myoma Recruiting NCT03550703 Phase 2
46 Denosumab in Subjects With Giant Cell Rich Tumors of Bone Recruiting NCT03605199 Phase 2 Denosumab
47 A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis Recruiting NCT01265030 Phase 1, Phase 2 Sirolimus
48 Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex Recruiting NCT03363763 Phase 2 Sirolimus 0.2%;Sirolimus 0.4%;Placebo ointment
49 Safety and Efficacy Study Using 5-ALA Oral Administration as an Adjuvant Therapy on the Rate of Local Tumor Recurrence in Patients Who Have Desmoids Tumors Recruiting NCT01898416 Phase 2 5-AMINOLEVULINIC ACID (5-ALA), is a non fluorescent prodrug.
50 PAZOPANIB Efficacy and Tolerance in Desmoids Tumors Recruiting NCT01876082 Phase 2 PAZOPANIB treatment;Active Comparator: Vinblastine and Methotrexate

Search NIH Clinical Center for Fibroma

Cochrane evidence based reviews: fibroma

Genetic Tests for Fibroma

Genetic tests related to Fibroma:

# Genetic test Affiliating Genes
1 Fibroma 30

Anatomical Context for Fibroma

MalaCards organs/tissues related to Fibroma:

42
Bone, Heart, Ovary, Breast, Skin, Kidney, Tongue

Publications for Fibroma

Articles related to Fibroma:

(show top 50) (show all 3038)
# Title Authors Year
1
Calcifying aponeurotic fibroma of the sole of the foot in an elderly patient. ( 31103838 )
2019
2
Surface-type chondromyxoid fibroma in an elderly patient: a case report and literature review. ( 30498967 )
2019
3
Fibroma of tendon sheath embedded in carpal bones mimicking carpal enchondroma: A case report. ( 31008967 )
2019
4
Very large Ameloblastic Fibroma with Calcifying Odontogenic Cyst in an 8-year-old child. Histological and immunohistochemical characterisation. ( 30919639 )
2019
5
Midfoot Plantar Fascia Tear Mimicking Plantar Fibroma. ( 30964312 )
2019
6
Ameloblastic fibroma in a young adult. ( 30967727 )
2019
7
Desmoid fibroma in the clavicle detected by 18F-NaF PET/CT. ( 30971380 )
2019
8
Management of massive peripheral ossifying fibroma using diode laser. ( 30983792 )
2019
9
Biventricular fibroma resection in an adult. ( 30990581 )
2019
10
Superficial radial nerve compression due to fibroma of the brachioradialis tendon sheath: A case report. ( 31031130 )
2019
11
Early presentation in ameloblastic fibroma. ( 31055094 )
2019
12
Desmoplastic fibroma associated with tuberous sclerosis: case report and literature review. ( 31078508 )
2019
13
Elimination of arrhythmogenesis after subtotal resection of congenital cardiac fibroma: a case report. ( 31097046 )
2019
14
Clarifying the dermoscopic features of irritation fibroma by mobile photograph editor application. ( 31102290 )
2019
15
Reconstruction and Mandibular Rehabilitation After Resection of Juvenile Aggressive Ossifying Fibroma Using Undifferentiated Mesenchymal Cells and Osseointegrated Implants: A Case Report. ( 31107685 )
2019
16
Can non-collagenous proteins be employed for the differential diagnosis among fibrous dysplasia, cemento-osseous dysplasia and cemento-ossifying fibroma? ( 31109869 )
2019
17
Intra-articular fibroma-like perivascular epithelioid tumor (PEComa) mimicking tenosynovial giant cell tumor, diffuse type. ( 30206676 )
2019
18
Management of an extensive equine juvenile ossifying fibroma by rostral mandibulectomy and reconstruction of the mandibular symphysis using String of Pearls plates with cortical and cancellous bone autografts. ( 30370537 )
2019
19
Elimination of arrhythmogenesis after subtotal resection of congenital cardiac fibroma: a case report. ( 30375307 )
2019
20
Mixed odontogenic tumors in four young dogs: ameloblastic fibroma and ameloblastic fibro-odontoma. ( 30451090 )
2019
21
Two-stage surgical treatment for a giant sellar psammomatoid juvenile ossifying fibroma: case report. ( 30611151 )
2019
22
Electrochemotherapy with cisplatin for the treatment of a non-operable cutaneous fibroma in a cockatiel (Nymphicus hollandicus). ( 30626280 )
2019
23
Fibroma of the Tendon Sheath Arising From the Flexor Digitorum Superficialis Tendon. ( 30680050 )
2019
24
Stereotactic radiosurgery as a treatment for recurrent ventricular tachycardia associated with cardiac fibroma. ( 30693205 )
2019
25
Gingival choristoma masquerading as fibroma. ( 30706888 )
2019
26
Skull Base Juvenile Psammomatoid Ossifying Fibroma: Clinical Characteristics, Treatment, and Prognosis. ( 30743026 )
2019
27
An Unusual Presentation of Ovarian Fibroma Originating from an Autoamputated Ovary. ( 30783589 )
2019
28
Fibroma of the patellar tendon sheath-a rare case in a young boy. ( 30783711 )
2019
29
Non-ossifying fibroma: a RAS-MAPK driven benign bone neoplasm. ( 30809793 )
2019
30
Fibrous Dysplasia and Juvenile Psammomatoid Ossifying Fibroma: A Case of Mistaken Identity. ( 30813749 )
2019
31
Reconstruction of the Proximal Aspect of the Radius After Desmoplastic Fibroma Resection: A Case Report. ( 30817326 )
2019
32
Multimodal radiological imaging of collagenous fibroma arising from the subacromial region in a patient with osteosarcoma: A case report. ( 30847175 )
2019
33
Unilateral visual loss resulting from orbital encroachment of an ethmoidal juvenile trabecular ossifying fibroma. ( 30854866 )
2019
34
A case of irritation fibroma. ( 30858793 )
2019
35
Cardiac Fibroma with Ventricular Tachycardia: An Unusual Clinical Presentation of Nevoid Basal Cell Carcinoma Syndrome. ( 30140199 )
2018
36
Intraarticular calcifying aponeurotic fibroma of the wrist: mimicking gout or calcium pyrophosphate dihydrate deposition disease. ( 29243144 )
2018
37
Calcifying Aponeurotic Fibroma of the Hallux A Case Report. ( 29547027 )
2018
38
Multiple calcifying aponeurotic fibroma: case report and review of the literature. ( 30701881 )
2018
39
Calcifying aponeurotic fibroma: a core biopsy-based diagnosis. ( 30799443 )
2018
40
Chondromyxoid Fibroma Arising in Craniofacial Sites: A Clinicopathologic Analysis of 25 Cases. ( 29324473 )
2018
41
Benign Chondromyxoid Fibroma of the Iliac Crest. ( 29385939 )
2018
42
Chondromyxoid Fibroma of the Metatarsal Bone: A Diagnosis Using Fine Needle Aspiration Biopsy. ( 29403178 )
2018
43
A case report on partial scapulectomy with glenoid preservation for Chondromyxoid fibroma of scapula. ( 29628714 )
2018
44
Treatment of cryotherapy and orthotopic transplantation following chondromyxoid fibroma of zygomatic bone: A case report. ( 30075574 )
2018
45
Huge chondromyxoid fibroma of the right iliac wing with tremendous soft tissue extensions. ( 30363225 )
2018
46
Chondromyxoid Fibroma of the Pelvis: Institutional Case Series With a Focus on Distinctive Features. ( 30580642 )
2018
47
Chondromyxoid fibroma with a secondary aneurysmal bone cyst of the distal radius: A case report. ( 30580890 )
2018
48
Chondromyxoid fibroma of the temporal bone: A case report and review of the literature. ( 30613685 )
2018
49
Letter to the Editor/Comments on "Endometrial cancer after ulipristal acetate for uterine fibroma" by Ignatov et al. Eur J Obstet Gynecol Reprod Biol 2017; Dec;219:134. ( 29287965 )
2018
50
Conservative Management of Ovarian Fibroma in A Case of Gorlin-Goltz Syndrome Comorbid with Endometriosis. ( 29334213 )
2018

Variations for Fibroma

Expression for Fibroma

Search GEO for disease gene expression data for Fibroma.

Pathways for Fibroma

Pathways related to Fibroma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
11.17 DES KRT14 VIM
2 10.66 ACTC1 DES VIM

GO Terms for Fibroma

Cellular components related to Fibroma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.56 ACTC1 COL12A1 CTNNB1 DES KRT14 MUC16
2 blood microparticle GO:0072562 9.5 ACTC1 F13A1 SERPINA3
3 Z disc GO:0030018 9.43 CTNNB1 DES S100A1
4 I band GO:0031674 9.37 ACTC1 S100A1
5 fascia adherens GO:0005916 9.16 CTNNB1 DES
6 cell periphery GO:0071944 8.8 CD34 CTNNB1 KRT14

Biological processes related to Fibroma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.67 ACTC1 CD34 CTNNB1 VIM
2 beta-catenin-TCF complex assembly GO:1904837 9.4 CDC73 CTNNB1
3 cell fate determination GO:0001709 9.26 CTNNB1 PTCH1
4 intermediate filament organization GO:0045109 9.16 DES VIM
5 renal system development GO:0072001 9.02 PTCH1
6 endodermal cell fate commitment GO:0001711 8.96 CDC73 CTNNB1
7 muscle filament sliding GO:0030049 8.8 ACTC1 DES VIM

Molecular functions related to Fibroma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 structural constituent of cytoskeleton GO:0005200 9.13 DES KRT14 VIM
2 keratin filament binding GO:1990254 8.62 KRT14 VIM

Sources for Fibroma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....